MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 160 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,298,000 | +60.7% | 253,400 | +1.9% | 0.01% | +42.9% |
| Q2 2020 | $8,274,000 | +38.3% | 248,700 | +13.0% | 0.01% | +16.7% |
| Q1 2020 | $5,984,000 | +40.1% | 220,000 | +1.6% | 0.01% | +50.0% |
| Q4 2019 | $4,272,000 | +87.4% | 216,500 | +23.1% | 0.00% | +100.0% |
| Q3 2019 | $2,280,000 | +5.2% | 175,900 | +1.0% | 0.00% | 0.0% |
| Q2 2019 | $2,168,000 | -10.2% | 174,100 | +4.8% | 0.00% | -33.3% |
| Q1 2019 | $2,415,000 | +34.5% | 166,200 | +2.2% | 0.00% | +50.0% |
| Q4 2018 | $1,795,000 | -46.9% | 162,600 | +26.4% | 0.00% | -50.0% |
| Q3 2018 | $3,382,000 | +31.6% | 128,600 | +2.4% | 0.00% | +33.3% |
| Q2 2018 | $2,569,000 | +12.7% | 125,600 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $2,280,000 | +32.6% | 125,600 | +1.9% | 0.00% | +50.0% |
| Q4 2017 | $1,720,000 | -19.6% | 123,300 | +6.6% | 0.00% | 0.0% |
| Q3 2017 | $2,140,000 | +9.5% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,955,000 | +33.0% | 115,700 | +5.1% | 0.00% | 0.0% |
| Q1 2017 | $1,470,000 | -11.3% | 110,100 | 0.0% | 0.00% | -33.3% |
| Q4 2016 | $1,657,000 | +28.7% | 110,100 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $1,287,000 | +4.8% | 110,100 | -3.2% | 0.00% | 0.0% |
| Q2 2016 | $1,228,000 | +23.4% | 113,700 | +2.1% | 0.00% | 0.0% |
| Q1 2016 | $995,000 | -26.7% | 111,400 | +21.7% | 0.00% | -33.3% |
| Q4 2015 | $1,358,000 | -7.2% | 91,500 | +2.6% | 0.00% | -25.0% |
| Q3 2015 | $1,464,000 | -18.3% | 89,200 | +13.5% | 0.00% | -20.0% |
| Q2 2015 | $1,793,000 | +105.1% | 78,600 | +36.7% | 0.01% | +150.0% |
| Q1 2015 | $874,000 | +31.2% | 57,500 | +4.0% | 0.00% | 0.0% |
| Q4 2014 | $666,000 | +6.2% | 55,300 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $627,000 | -6.1% | 55,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $668,000 | +3.7% | 55,300 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $644,000 | -17.5% | 55,300 | +25.1% | 0.00% | 0.0% |
| Q4 2013 | $781,000 | +22.8% | 44,200 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $636,000 | -4.5% | 44,200 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $666,000 | – | 44,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |